BELLWAVE-003: A phase 2 dose escalation, confirmation, and cohort expansion study of nemtabrutinib in hematologic malignancies.
Autor: | Perini, Guilherme Fleury, Owen, Carolyn, Ozcan, Muhit, Jurczak, Wojciech, González Barca, Eva, Wrobel, Tomasz, Lavie, David, Chaudhry, Arvind, Ghia, Paolo, Xu, Yan, Boardman, David, Yang, Jing, Benjamini, Ohad |
---|---|
Zdroj: | Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pTPS7593-TPS7593, 1p |
Databáze: | Supplemental Index |
Externí odkaz: |